Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes

September 3, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search